MarketPeel
Insider Trading Intelligence
FD

Filip Dubovsky

NVAX
PRESIDENT, R&D · NOVAVAX INC · CIK 0001977361
FILING MIX · LIFETIME36%/64%
BUYS
10
SELLS
18
TOTAL VALUE
$1.47M
COMPANIES
1
ACTIVE SINCE
Jun 2023
HOLDINGS NOW
80,517
AVG SELL PX
$11.18
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Filip Dubovsky, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+3.39%+0.20%+3.20%+0.26%
14d3+66.67%-1.23%+0.41%-1.65%-9.39%
30d3+0.00%+12.42%+2.64%+9.79%+10.69%
60d3+100.00%-6.09%+3.55%-9.64%-9.40%
90d3+100.00%-8.06%+2.88%-10.95%-9.26%
180d3+100.00%-34.49%+12.47%-46.96%-46.30%
1y3+100.00%-54.47%+11.64%-66.11%-64.42%
2y3+100.00%-33.99%+39.32%-73.31%-71.67%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NVAX · 80,517 shares · as of Jun 17, 2024
036,00072,000108,000144,0002024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
FLOW · 10 buys / 18 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NVAX
NOVAVAX INC
PURCHASE
President, R&D
1,404$6.97$9.8K68,017Jun 17, 2024Jun 20, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
12,500$6.09$76.1K37,500Jun 17, 2024Jun 20, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
1,404$14.54$20.4K66,613Jun 17, 2024Jun 20, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
1,404$6.97$9.8K46,324Jun 17, 2024Jun 20, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
12,500$14.46$180.8K68,017Jun 17, 2024Jun 20, 2024View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
12,500$6.09$76.1K80,517Jun 17, 2024Jun 20, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
19,65247,728May 14, 2024May 15, 2024View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
19,652$6.97$137.0K86,265May 14, 2024May 15, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
47,312$13.90$657.6K38,953May 14, 2024May 15, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
5,3765,376Mar 10, 2024Mar 12, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
2,597$5.45$14.2K66,613Mar 10, 2024Mar 12, 2024View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
5,37669,210Mar 10, 2024Mar 12, 2024View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
19,44473,226Mar 7, 2024Mar 11, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
19,4440Mar 7, 2024Mar 11, 2024View →
NVAX
NOVAVAX INC
SALE
President, R&D
9,392$5.61$52.7K63,834Mar 7, 2024Mar 11, 2024View →
NVAX
NOVAVAX INC
PURCHASEGRANT
Stock grant
144,000144,000Mar 1, 2024Mar 26, 2024View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
2,833$5.69$16.1K55,150Dec 14, 2023Dec 18, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
1,368$5.69$7.8K53,782Dec 14, 2023Dec 18, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
2,8330Dec 14, 2023Dec 18, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
1,4000Nov 5, 2023Nov 7, 2023View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
1,400$7.06$9.9K52,994Nov 5, 2023Nov 7, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
677$7.06$4.8K52,317Nov 5, 2023Nov 7, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
6,108$7.71$47.1K51,594Sep 16, 2023Sep 19, 2023View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
12,644$7.71$97.5K57,702Sep 16, 2023Sep 19, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
12,6440Sep 16, 2023Sep 19, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
4,1550Jun 16, 2023Jun 21, 2023View →
NVAX
NOVAVAX INC
SALE
President, R&D
2,007$8.04$16.1K45,058Jun 16, 2023Jun 21, 2023View →
NVAX
NOVAVAX INC
PURCHASE
President, R&D
4,155$8.04$33.4K47,065Jun 16, 2023Jun 21, 2023View →
Other insiders · NVAX
Loading peer insiders…
About this filer
CIK 0001977361
ROLE
President, R&D
PRIMARY
NVAX
COMPANIES
1
ACTIVE SINCE
Jun 2023
MARKETPEEL · /INSIDER/0001977361DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback